Preeclampsia is considered to be a multifactorial and multisystemic disorder with a genetic predisposition. Alterations in the reninangiotensin system are considered to play a significant role in the pathogenesis of the disease. In order to investigate the possible association of the three most common polymorphisms of the renin-angiotensin system genes with preeclampsia we have examined 41 women with preeclampsia and 102 normotensive pregnant women. DNA samples were genotyped for the M235T polymorphism of the angiotensinogen gene (AGT), the insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme gene (ACE) and the A1166C polymorphism of the angiotensin II type 1 receptor gene (AT1R) by PCR. Allele and genotype frequencies of the AGT gene polymorphism differed between the two study groups. The TT genotype of the M235T polymorphism was significantly increased in women who developed preeclampsia (P < 0:02). In addition, women with preeclampsia and TT genotype had more frequently the DD genotype or the 1166C allele than the control group showing a significant interaction between the genes. In conclusion, we found an association between the angiotensinogen variant 235T and preeclampsia as well as an interaction between the variant 235T and the two other genes studied. #
Introduction
Preeclampsia is a relatively common complication of pregnancy with an incidence of $5%, associated with increased perinatal morbidity and mortality [1] . Epidemiological and family based studies in several geographically and ethnically distinct populations [2] indicate that preeclampsia is a multifactorial disorder with a familial tendency and it is influenced by race, parity, health status of placenta, diet and body size [3] . First degree relatives of women with preeclampsia have a fivefold increased risk while second degree relatives have twofold increased risk of having the disease compared with women who have no family history [4] . Pedigree analysis [4, 5] have suggested that maternal susceptibility could be due to autosomal recessive inheritance of a single gene difference, or incomplete penetrance of an autosomal dominant gene effect, or of multigenic aetiology. Furthermore, chromosome exclusion mapping, assuming autosomal recessive inheritance, suggested a role for a gene or genes on chromosomes 1, 3, 9, or 18 [6] and genome-wide scans revealed evidence for candidate regions on chromosomes 4 [7] , 7 [8] and 2 [9] .
The renin-angiotensin system (RAS) has a central role in blood pressure regulation during pregnancy [10] . Many investigators have postulated that alterations in the RAS play a significant role in the pathophysiology of preeclampsia. During normal pregnancy the RAS is stimulated and plasma renin activity (PRA), angiotensinogen (AGT), angiotensin II (AngII) and aldosterone levels are increased [11] . However, in women who develop preeclampsia suppression of the RAS system has been observed [12] . Human linkage and association genetic studies have revealed the presence of polymorphisms in genes encoding key components of the RAS that account for the proportion of the variance in activity of this system [13] [14] [15] . Studies of these polymorphisms reported both positive [16, 17] and negative association with preeclampsia [18, 19] . However, although the association of each of these polymorphisms with preeclampsia has been studied extensively, there are no available data of the possible synergistic effect of these variants. The aim of this study was to examine the three most common polymorphisms of the RAS genes [the M235T polymorphism of the AGT gene, the insertion/deletion polymorphism of the ACE gene (ACE ID), and the A1166C polymorphism of the AT1R gene] in women with preeclampsia in order to investigate the potential synergistic effect of these genetic alterations with the disease.
Materials and methods
We studied 41 women with singleton pregnancy complicated by preeclampsia and 102 control subjects of Hellenic origin (north-western Greece). Preeclampsia was defined as the development of blood pressure of 140/90 mmHg or greater on two occasions more than 2 h apart with proteinuria >300 mg/l in a random specimen or an excretion of >300 mg per 24 h after 20 weeks of gestation in a woman who was normotensive before pregnancy without preexisting cardiovascular or renal disease. All these features were resolved within 3 months postpartum. The control group that consisted of normotensive pregnant women had undergone at least two pregnancies with no history of preeclampsia and were recruited from the same center at the same time.
Genomic DNA from each individual was isolated from peripheral blood leucocytes using a standard NaCl extraction procedure technique. The DNA samples were genotyped for the M235T polymorphism of the angiotensinogen gene (AGT), the ID polymorphism of the angiotensin-converting enzyme gene (ACE) and the A1166C polymorphism of the angiotensin II type 1 receptor gene (AT1R). The AGT M235T genotype was determined by PCR amplification followed by digestion with restriction enzyme Tth111I according to the described method [20] . The ID polymorphism in intron 16 of the ACE gene was detected according to Rigat [13] . PCR is known to have a tendency to preferentially amplify short alleles in contrast to larger alleles in a competitive amplification reaction containing two alleles of different sizes as it is the case in ACE I versus D alleles. To increase specificity and to avoid preferential amplification of the deletion allele in heterozygotes, DD homozygotes were retyped using insertion-specific primers. To determine the AT1R A1166C genotype, PCR amplification was also performed under previously described conditions [21] and PCR products were digested by DdeI.
Statistical analysis
Data are presented as means AE S:D:. The levels of the variables were compared between the two study groups using analysis of variance (ANOVA). Hardy-Weinberg equilibrium was calculated by w 2 test. Statistical analyses were based on the calculation of odds ratios (ORs) to provide an estimate of the relative risk of preeclampsia associated with genotypes. The analyses were carried out by means of logistic regression models. Odds ratio was defined as the odds of a preeclamptic woman having a specific genotype divided by the odds of a normotensive pregnant woman having the same genotype. Interaction between the genotypes was estimated by introducing interaction terms in the logistic model.
Results
Clinical and demographic data of the two groups are shown in Table 1 . There were no maternal deaths in both groups and all babies were born alive. The gestational age at delivery and the neonatal birth weight was significantly lower, whereas the systolic blood pressure and the diastolic blood pressure was significantly higher in the group with preeclampsia compared to the normal controls.
Genotype frequencies for the AGT, ACE, and AT1R genes are shown in Table 2 . The values predicted by assumption of Hardy-Weinberg equilibrium for the three polymorphisms were similar to those observed in the group with preeclampsia as well as in the control group. The genotype distribution of the AGT M235T polymorphism differed significantly between preeclamptic and normotensive women. Compared to the control individuals, the frequency of homozygotes for the T allele was significantly higher in preeclamptic women. An odds ratio of 7.92 was calculated for the AGT TT genotype ( Table 3 ). The frequencies of the DD, ID and II genotypes of the ACE gene were not significantly different between preeclamptic and normotensive pregnant women but we noticed excess for carriers for the DD genotype in preeclamptic women compared to the frequency of the DD genotype in the control group (Table 2 ). An odds ratio of 2.44 was estimated for the ACE DD genotype although not statistically significant (Table 3 ). In the AT1R gene the frequency distribution for the A1166C polymorphism in preeclamptic women was also similar to that in normotensive pregnant women, but we found the CC genotype to be more frequent in preeclamptic than normotensive pregnant women. To further identify a genetic risk for preeclampsia, we tested the synergistic effect of the AGT TT genotype which has been found in this study to be associated with preeclampsia with either the unfavorable DD genotype of the ACE polymorphism or the C allele containing the genotypes (AC, CC) of the AT1R gene (Table 4 ). Due to the low frequency of the CC genotype in our study population we combined CC with AC to facilitate statistical analysis. We found a significant interaction (P < 0:01) between the AGT and ACE polymorphism on the risk of preeclampsia. The association between the AGT TT genotype and preeclampsia was restricted to subjects carrying the D allele, with a pronounced allele dose-effect. Regarding the AT1R gene polymorphism, women with preeclampsia and TT genotype had more frequently the C allele of the AT1R gene than normotensive pregnant women showing also a significant interaction (P < 0:01) between these two polymorphisms.
Discussion
The absence of stimulation of the RAS in women developing hypertension during pregnancy or in women with preeclampsia has been confirmed by many studies [12] . The entire renin-angiotensin axis is affected in established preeclampsia, in particular, plasma renin concentrations are markedly decreased and there has been considerable recent interest in the possible role of alteration in the RAS in the pathophysiology of preeclampsia. There is extensive evidence that plasma renin activity, plasma renin concentration, angiotensin II, angiotensinogen and plasma urinary aldosterone levels are all lower in preeclampsia compared with normotensive pregnant women [12] . Several laboratories have reported increased density of platelet AngII receptors and increased AngII binding in preeclamptic women compared to normal pregnant women [22] . Since the RAS plays an integral role in the pathophysiology of preeclampsia it is tempting to speculate that the genetic variants may play a role in the development of preeclampsia.
Statistical analysis revealed an association between AGT M235T variant and preeclampsia. Specifically, our data show an increased risk for preeclampsia in women carrying the AGT TT genotype. In accordance to other investigators [18, 19] we did not find an association between the ACE ID polymorphism but we noticed an increased OR for women carrying the DD genotype of the ACE gene. To our knowledge, there have been no reports as to whether interaction between specific polymorphisms of the ACE, AGT and AT1R genes has an impact on pregnancy complicated by preeclampsia. To study the putative specific effect of the ACE ID polymorphism subsequent stratification was performed with respect to the M235T genotypes. We found a significant interaction between the AGT and ACE gene polymorphisms on the risk of preeclampsia. The association between the ACE DD genotype and preeclampsia was restricted to preeclamptic women carrying the M235T alleles. A synergistic effect has been shown in other studies where the TT genotype in M235T polymorphism in combination with the C allele in A1166C polymorphism enhance the relative risk of myocardial infarction in patients with the DD genotype of ACE [15, 21] . There were no significant differences in the frequency of AT1R polymorphism among the groups studied.
To further identify a genetic risk for preeclampsia we tested the interaction of the CC genotype of the AT1R gene and the TT genotype of the AGT gene. We found a significant increased risk for preeclampsia in women carrying the C allele of the AT1R gene and the TT genotype of the AGT gene. Although the mechanism associating preeclampsia and RAS polymorphisms is still unclear, several studies have confirmed that particular RAS polymorphisms are positively associated with preeclampsia and that in addition to the classical circulating RAS, there are local de novo RAS that locally generate AngII [16, 17] . It has also been reported [17] that the AGT gene may function as part of a spiral artery RAS that has a role in spiral artery remodeling and that the AGT 235T allele may be a marker of failed physiologic change, because the AGT expression may lead to elevated local AngII levels.
In summary, an increased risk for preeclampsia in women carrying the TT genotype of the AGT gene was observed. The ACE ID polymorphism and the AT1R allelic variants do not seem to be independently and directly associated with preeclampsia in our population, but they seem to modulate the risk conferred by the AGT T allele. The number of patients included in this study is probably not enough to draw definite conclusions about the synergistic effect of the three genes studied. However, these results enhance the hypothesis, that not only one but many interacting loci with functional allelic variants of the RAS confer to genetic predisposition to preeclampsia. Consequently, combinations of polymorphisms in several genes may act synergistically to increase the risk of preeclampsia and larger studies will be needed to prove this hypothesis.
